BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1306238)

  • 1. [Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma].
    Ohira T; Ohe Y; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():48-51. PubMed ID: 1306238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline.
    Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
    Gene Ther; 1994 Jul; 1(4):269-75. PubMed ID: 7584091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
    Tanaka M; Saijo Y; Sato G; Suzuki T; Tazawa R; Satoh K; Nukiwa T
    Cancer Gene Ther; 2000 Nov; 7(11):1481-90. PubMed ID: 11129290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy with GM-CSF, interleukin-4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancer.
    Park KH; Kim G; Jang SH; Kim CH; Kwon SY; Yoo CG; Kim YW; Kwon HC; Kim CM; Han SK; Shim YS; Lee CT
    Anticancer Res; 2003; 23(2B):1559-64. PubMed ID: 12828142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor effect of interleukin-2 gene-transfected tumor vaccine in combination with interleukin-6 gene-transfected tumor vaccine].
    Cao X; Zhang W; Tao Q
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):602-5, 639. PubMed ID: 8697075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
    Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
    J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
    Yin XL; Duan H; Peng ZP; Sun SL; Li SL
    Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells.
    Ohe Y; Podack ER; Olsen KJ; Miyahara Y; Ohira T; Miura K; Nishio K; Saijo N
    Int J Cancer; 1993 Feb; 53(3):432-7. PubMed ID: 8428797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
    Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.
    Porgador A; Tzehoval E; Katz A; Vadai E; Revel M; Feldman M; Eisenbach L
    Cancer Res; 1992 Jul; 52(13):3679-86. PubMed ID: 1617640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
    Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice.
    Provinciali M; Argentati K; Tibaldi A
    Gene Ther; 2000 Apr; 7(7):624-32. PubMed ID: 10819579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
    Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
    Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local IL-4 delivery enhances immune reactivity to murine tumors: gene therapy in combination with IL-2.
    Pippin BA; Rosenstein M; Jacob WF; Chiang Y; Lotze MT
    Cancer Gene Ther; 1994 Mar; 1(1):35-42. PubMed ID: 7621236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice.
    Sturlan S; Beinhauer BG; Oberhuber G; Huang L; Aasen AO; Rogy MA
    Anticancer Res; 2002; 22(5):2547-54. PubMed ID: 12529962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism.
    Pulaski BA; McAdam AJ; Hutter EK; Biggar S; Lord EM; Frelinger JG
    Cancer Res; 1993 May; 53(9):2112-7. PubMed ID: 8097675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice.
    Ohe Y; Podack ER; Olsen KJ; Miyahara Y; Miura K; Saito H; Koishihara Y; Ohsugi Y; Ohira T; Nishio K
    Br J Cancer; 1993 May; 67(5):939-44. PubMed ID: 8494727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.